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Abstract Tissue distribution of the five identified classes of 
human alcohol dehydrogenase was studied by assessment of 
mRNA levels in 23 adult and four fetal tissues. Alcohol 
dehydrogenase of class I was found in most tissues, brain and 
placenta excluded, but expression levels among tissues differed 
widely. The distribution pattern of class III transcripts was 
consistent with those of housekeeping enzymes while, in contrast, 
class IV transcripts were found only in stomach. Transcripts of 
multiple length were detected for most classes and were due to 
different gene products arising through the use of different poly- 
A signals or transcription from different gene loci. Both class II 
and class V showed a pattern of liver-enriched expression. 
However, low mRNA levels were detected also in stomach, 
pancreas and small intestine for class II, and in fetal kidney and 
small intestine for class V. Significantly higher levels of class V 
transcripts were present in fetal liver when compared with levels 
in adult liver, which suggests that human class V is a 
predominantly fetal alcohol dehydrogenase. 
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1. Introduction 
Mammalian alcohol dehydrogenases (ADH, EC 1.1.1.1) 
comprise a family of enzymes divided into six classes accord- 
ing to function and structure [l]. Today, five classes of human 
ADH have been identified and an additional class has been 
defined in rodents [2,3]. Enzymes of ADH classes are capable 
of ethanol metabolism but display broad substrate specifici- 
ties, and have been suggested to play a role in cellular detox- 
ification mechanisms [4,5]. Class I, the classical ADHs, are 
abundant in liver and are the major enzymes in the first 
step of ethanol metabolism. This class is subdivided into iso- 
zymes consisting of three different subunits. The a-subunit is 
expressed during early fetal development while the expression 
of the P-subunit appears by midgestation, and the y-subunit is 
postnatally expressed [6]. The y-subunit is the type of human 
class I ADH that most closely relates to other non-primate 
mammalian class I ADHs. 
Class II ADH activity has been found mainly in liver and 
the human enzyme shows a high K,, value for ethanol [7]. 
Class III ADH, identical to glutathione-dependent formalde- 
hyde dehydrogenase, is a poor ethanol dehydrogenase but has 
been proposed to play a significant role in cytoprotection by 
metabolism of formaldehyde [8]. Class IV is extra-hepatically 
expressed with high ethanol metabolising activity in stomach 
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mucosa [9,10] and so far class V has only been isolated at the 
DNA level and characterised as a recombinantly expressed 
enzyme [11,12]. 
Several studies have reported on the tissue occurrence of 
ADHs in human tissues [6,10,13-191. These studies have 
been carried out at both the transcript and protein levels 
but have the disadvantage that they, in a single experiment, 
delineate the distribution of one or a few classes in a restricted 
number of tissues. Most of the distribution data is available 
on ADH enzymes of classes I, III and IV, although a total of 
five different ADH classes are recognised at present. To now 
further extend the knowledge on the relative tissue occurrence 
of all human ADHs, we have examined mRNA levels for 
ADH of classes I-V in an extensive number of adult and fetal 
tissues, all potential targets of direct or indirect toxic effects of 
ethanol. 
2. Materials and methods 
2.1. Cloning of cDNAs encoding ADH of classes IV and V 
.The class IV ADH cDNA was PCR amplified from human stomach 
cDNA (Quick-clone, Clontech) using the primers 5’-TTTCA- 
TATGGGCACTGCTGGAAAAGTTA-3’ and 5’-TTTGGATCCT- 
CAAAACGTCAGGACCGTTC-3’, designed according to the pub- 
lished gene sequence [20]. Amplified cDNA was cloned into the 
pCRI1 vector (Invitrogen) using the TA cloning method [21]. 
An internal 500-bp fragment of the cDNA coding for human class 
V ADH [ll] was PCR amplified from a human liver cDNA library 
(Clontech). A 5’ primer, 5’-CCTGAATTCTGAGGGCAATTTTT- 
CT-3’, and a 3’ primer, 5’-GCGAATTCCAATGGCCTCAAAGCA- 
GAA-3’, were used. Both primers contained EcoRI sites for cloning 
into pEMBL9 vectors. DNA sequence analysis was performed on 
both PCR products to confirm the authenticity of the cDNAs. 
2.2. Northern-blot analysis 
Northern-blot filters, containing approximately 2 lg poly-A-en- 
riched RNA from each tissue, were purchased and used according 
to the recommendations by the manufacturer (Clontech). Class I 
mRNA was probed with a 400-bp BstEII cDNA fragment from a 
class I y cDNA clone [22], and class II with a 440-bp TaqI fragment 
from a class II cDNA clone [23]. A 390-bp EcoRI fragment [24] and a 
400-bp EcoRI fragment ([11], cf. above) served as probes for class III 
and class V, respectively. Utilising the PCR technique, a 689-bp class 
IV probe was amplified from the isolated class IV cDNA, using the 
primers 5’-CAGAAGCAACCCTTCTCCATTG-3’ and 5’-GGTA- 
GAGTCCTTGGGACTGATAC-3’. In addition, all filters were 
probed with a 2-kb fragment of human p-actin cDNA. All probes 
were labelled with [a-32P]dCTP to a specific activity of 5 x lo* cpm/ 
Kg (rediprime DNA labelling system; Amersham). Hybridisations 
were performed at 42°C overnight in 50% formamide, SXSSPE, 
10X Denhardt’s solution, 2% SDS and 1 mdml salmon sperm 
DNA. Filters were washed with high stringency (0.1 xSSC, h.l% 
SDS, at 42°C) before exuosure to Kodak X-OMAT films for 12- 
118 h using intensifying screens. The cDNA probes were removed 
from the filters by washing in 0.1 XSSC, 0.5% SDS at 95°C for 10 
min before rehybridisation for a new ADH class. To ensure removal 
of probes the filters were subjected to autoradiography for 46 h be- 
tween the hybridisations. 
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Fig. 1. Northern-blot analysis of class I ADH in human tissues. A: Filters were hybridised with a 400-bp cDNA fragment coding for the y-sub- 
unit of class I. X-ray films were exposed for 44 h. B: Filters were hybridised with cDNA coding for @actin and X-ray films were exposed for 
12 h 
3. Results and discussion 
Tissue distribution of the five known classes of human al- 
cohol dehydrogenase was assessed by hybridising filters con- 
taining mRNA from 23 adult and four fetal tissues with 
cDNA probes specific for ADH transcripts of classes I-V 
(Figs. l-5). As a control, filters were also probed with a 
cDNA coding for constitutivly expressed P-actin (Fig. lb). 
Class I transcripts showed a wide distribution, although 
expression levels varied considerably among different tissues 
(Fig. la). Adult liver showed the highest levels of class I ADH 
mRNA, but large amounts were also found in stomach, small 
intestine, colon, adrenal cortex, heart, as well as fetal lung, 
liver and kidney. In total, transcripts of five sizes were found. 
Three of these were represented by strong autoradiography 
signals at 1.5, 1.9 and 2.8 kb, while signals corresponding to 
4.3 and 5.5 kb were faint. The probe used for class I ADH, 
cross-hybridised with transcripts originating from all three 
class I loci (ADHI-3), which give rise to the a-, p- and y- 
subunits [25]. The different sizes of class I transcripts can be 
explained by transcription from the three different loci and the 
use of alternative poly-A signals [14,15,26]. A previous study 
on class I isozyme expression in liver has shown that only the 
ADH2 locus, coding for the P-subunit, gives rise to transcripts 
of about 2.8 kb [14]. This implies that the PP-isozyme is the 
major class I isozyme in heart, skeletal muscle, pancreas, 
spleen, prostate, ovary, adrenal medulla, adrenal cortex, thyr- 
oid, small intestine, lymph node and lung (Fig. la), because 
the 2.8 kb transcripts predominate in these tissues. The lung 
has been proposed to be a site for significant extra-hepatic 
ethanol metabolism, and it has been shown that the pp-iso- 
zyme is the only abundant ADH form in this tissue at all 
stages of development [6,27]. In the testis, only very faint class 
I signals were detected. This is in accordance with previous 
results showing that testicular homogenates have only class III 
ADH activity [16]. 
The mRNA coding for the fetally expressed a-subunit cor- 
responds to the 1.5 kb transcript, but message of this size is 
also shared by mRNA coding for the y-subunit. The apparent 
differences in tissue specific expression from the three ADHI- 
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Fig. 2. Northern-blot analysis of class II ADH. Filters were hybridised with a 440-bp cDNA fragment coding for human class II ADH. X-ray 
films were exposed for 94 h. 
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Fig. 3. Northern-blot analysis of class III ADH. Filters were hybridised with a 390-bp cDNA fragment coding for human class III ADH. 
X-ray films were exposed for 46 h. 
loci may be explained by small differences in their proximal 
promoters, which affect binding affinities for transcription fac- 
tors [28]. Class I transcripts were detected in fetal kidney, but 
not in in adult kidney. The lack of class I ADH mRNA in 
adult kidney is in agreement with a recent study [19], but 
stands in contrast to both an earlier study which showed 
the presence of class I ADH PO-isozyme in human kidney 
[6] and to a report on tissue-specific gene expression [28]. 
ADH catalysis of ethanol yields the toxic product acetalde- 
hyde which is further metabolised mainly by aldehyde dehy- 
drogenase (ALDH). It is of interest to notice that the cytosolic 
aldehyde dehydrogenase, ALDH 1, is expressed in similar tis- 
sues as class I ADH, while transcripts of the mitochondrial 
form, ALDH2, are present in every investigated tissue with 
the exception of placenta [29]. In addition, as found with class 
I ADH, high levels of ALDH2 expression were found only in 
the liver. 
Control hybridisations with a p-actin probe confirmed that 
fairly equal amounts of mRNA were present on the filters 
(Fig. lb). Pancreas, spleen, thymus, testis, small intestine, per- 
ipheral blood leukocyte and fetal liver were represented in 
duplicates on the filters and shared virtually identical hybridi- 
sation patterns when probed for expression of both p-actin 
and the different ADHs. Class I transcripts, however, differed 
between the two samples of fetal liver. This was most likely 
due to the different origin of these two mRNA samples. One 
of the fetal liver blots (left fetal liver in Fig. la) represents a 
mRNA pool from 22-26-week fetuses, while the other blot 
(right fetal liver in Fig. la) represents mRNA from 18-24- 
week fetal livers. It is known that transcripts coding for the 
P-subunit appear by midgestation, and therefore the appear- 
ance of the 2.8 kb mRNA in the blot to the left can be 
explained. 
As opposed to class I, mRNA of class II ADH was ex- 
pressed mainly in liver, although faint signals could be seen 
for small intestine, pancreas and stomach (Fig. 2). Our present 
finding of transcripts in the human small intestine could agree 
with a previous investigation of class II in rat tissues which 
showed high levels of mRNA expression also in duodenum 
[30]. The class II enzyme can catalyse oxido-reduction of a 
broad range of alcohols and the corresponding aldehydes 
[7,31]. In addition, both quinone reduction and aldehyde dis- 
mutation activities have been observed for this ADH enzyme 
[32,33]. Because the liver is the major site for turnover of 
xenobiotic substrates, the limited tissue expression together 
with the broad substrate specificity imply a possible role for 
class II ADH in the metabolism of various exogenous com- 
pounds. 
Class 111 showed quite a different distribution pattern than 
the other classes, with transcripts found in all analysed tissues. 
Inter-tissue variation was very low with the exception of brain 
and placenta, where levels were significantly lower than aver- 
Fig. 4. Northern-blot analysis of class IV ADH. Filters were hybridised with a 689-bp PCR amplified cDNA fragment coding for human class 
IV ADH. X-ray films were exposed for 74 h. 
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Fig. 5. Northern-blot analysis of class V ADH. Filters were hybridised with a 400-bp cDNA fragment coding for human class V ADH. X-ray 
films were exposed for 118 h 
age (Fig. 3). Like for ADHs of class II and class V, transcripts 
of two different sizes were found. The ratio between the two 
transcripts differs widely among tissues. In brain, transcripts 
of 2.8 kb, but not 1.6 kb, were found while the opposite was 
found for placenta. These differences in mRNA size are most 
likely due to the use of different poly-A signals [24], although 
the functional significance of this length polymorphism is not 
known. The 5’ region of the ADHS gene, coding for class III 
ADH, shows typical characteristics of a constitutively ex- 
pressed gene with many CpG doublets and lack of both 
TATA and CAAT boxes [34]. The housekeeping character 
of class III ADH is confirmed by its ubiquitous expression 
and is in accordance with its suggested role in formaldehyde 
scavenging [8,34,35]. 
In human tissue, class IV ADH activity has been detected 
mainly in stomach mucosa [9,10], but also in esophagus [17] 
gingiva and tongue [36]. Similarly, the rat class IV enzyme, 
denoted ADH-I, has been found in many organs including 
skin, eyes, ear mucose, nasal mucose, trachea, lungs, buccal 
mucose, tonge, esophagus, rectum, penis and vagina [37]. 
These results, like ours of class IV ADH (Fig. 4) suggest a 
mainly endo/epithelial localisation and are in agreement with 
earlier transcript distribution results [19]. However, a high 
background was obtained for the class IV Northern-blot anal- 
ysis (Fig. 4) probably due to decrease in quality of the filters 
used after several rehybridisations. The expression pattern of 
class IV ADH has further been correlated to retinoic acid 
localisation in mouse [38] and the class IV enzyme may play 
an integral part of the metabolism of retinol [39]. 
The class V ADH gene has been cloned [1 11, but the func- 
tion and substrate specificities of the corresponding enzyme 
are unknown. Low levels of class V transcript were detected in 
small intestine and fetal kidney. Significantly higher levels of 
mRNA, however, were detected in fetal liver as compared to 
adult liver (Fig. 5). This pattern of expression resembles that 
of the class I aa-isozyme [6] which strongly suggests that class 
V ADH is a fetal liver enzyme. 
Taken together, the separate transcripts investigated for the 
human ADH classes display discrete patterns of tissue distri- 
bution and indicate that ADH activity is present in all human 
tissues. Most of the ADH classes were expressed at high levels 
in the liver, but whether these liver transcripts can be regarded 
as representative of amounts of the corresponding enzyme 
activity remains to be revealed. Clearly, however, liver tissue 
accounts for the vast majority of ethanol metabolism in the 
human body, and it is the single tissue in which morphological 
changes occur early upon alcohol consumption. Although 
ADH and ALDH activities may be of importance in the con- 
cept of ethanol-induced hepatotoxicity, the setup of different 
classes of ADH with characteristic expression patterns argues 
in favour of a functional divergence and suggests additional 
specific functions for all ADH classes other than the oxidation 
of ingested alcohol. 
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